Индапамид в лечении артериальной гипертензии

Обложка

Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Доступ платный или только для подписчиков

Аннотация

Диуретики относятся к препаратам первого ряда для лечения артериальной гипертензии. Имеющиеся данные подтверждают снижение заболеваемости и смертности, преимущества контроля объема и натрийуреза, в частности, для снижения риска развития сердечной недостаточности при применении диуретических средств. Вместе с тем эта группа включает достаточно разнородные препараты, среди которых особое место занимает тиазидоподобный диуретик индапамид. Оптимальное соотношение эффективности и безопасности делает его препаратом выбора как при монотерапии, так и комбинированной терапии различных групп пациентов с артериальной гипертензией.

Полный текст

Доступ закрыт

Об авторах

Андрей Валентинович Сыров

ФГАОУ ВО «Российский университет дружбы народов» (РУДН)

Автор, ответственный за переписку.
Email: syrman2002_1@yahoo.com
ORCID iD: 0000-0002-2536-5781

к.м.н., доцент кафедры общей врачебной практики медицинского института

Россия, г. Москва

Список литературы

  1. Клинические рекомендации. Артериальная гипертензия у взрослых. Общероссийская общественная организация «Российское кардиологическое общество». Рубрикатор клинических рекомендаций Минздрава России. 2020. ID: 62. Доступ: https://cr.minzdrav.gov.ru/schema/62_2 (дата обращения – 01.05.2023).
  2. Williams B., Mancia G., Spiering W. et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018; 36(10): 1953–2041. https://dx.doi.org/10.1097/HJH.0000000000001940.
  3. Gabb G., Mangoni A., Arnolda L. Guideline for the diagnosis and management of hypertension in adults – 2016. Med J Aust. 2017; 206(3): 141. https://dx.doi.org/10.5694/mja16.01132.
  4. Leung A., Daskalopoulou S., Dasgupta K. et al. Hypertension Canada’s 2017 Guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults. Can J Cardiol. 2017; 33(5): 557–76. https://dx.doi.org/10.1016/j.cjca.2017.03.005.
  5. Task Force of the Latin American Society of Hypertension. Guidelines on the management of arterial hypertension and related comorbidities in Latin America. J Hypertens. 2017; 35(8): 1529–45. https://dx.doi.org/10.1097/HJH.0000000000001418.
  6. Whelton P., Carey R., Aronow W. et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018; 71(19): e127–e248. https://dx.doi.org/10.1016/j.jacc.2017.11.006.
  7. National Clinical Guideline Centre. Hypertension. The clinical management of primary hypertension in adults (NICE clinical guideline 127). London, United Kingdom. 2011. URL: https://www.nice.org.uk/guidance/ng136/evidence/full-guideline-pdf-6898565198 (date of access – 01.05.2023).
  8. Roush G., Ernst M., Kostis J. et al. Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: Antihypertensive and metabolic effects. Hypertension. 2015; 65(5): 1041–46. https://dx.doi.org/10.1161/HYPERTENSIONAHA.114.05021.
  9. Liang W., Ma H., Cao L. et al. Comparison of thiazide-like diuretics versus thiazide-type diuretics: A meta-analysis. J Cell Mol Med. 2017; 21(11): 2634–42. https://dx.doi.org/10.1111/jcmm.13205.
  10. Roush G., Abdelfattah R., Song S. et al. Hydrochlorothiazide vs chlorthalidone, indapamide, and potassium-sparing/hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: A systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2018; 20(10): 1507–15. https://dx.doi.org/10.1111/jch.13386.
  11. Burnier M., Bakris G., Williams B. Redefining diuretics use in hypertension. Why select a thiazide-like diuretic? J Hypertension. 2019; 37(8): 1574–86. https://dx.doi.org/10.1097/HJH.0000000000002088.
  12. Liu L., Wang Z., Gong L. et al. Blood pressure reduction for the secondary prevention of stroke: A Chinese trial and a systematic review of the literature. Hypertension Research. 2009; 32(11): 1032–40. https://dx.doi.org/10.1038/hr.2009.139.
  13. PROGRESS Collaborative group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001; 358(9287): 1033–41. https://dx.doi.org/10.1016/S0140-6736(01)06178-5.
  14. ADVANCE Collaborative Group. ADVANCE – Action in Diabetes and Vascular Disease: Patient recruitment and characteristics of the study population at baseline. Diabet Med. 2005; 22(7): 882–88. https://dx.doi.org/10.1111/j.1464-5491.2005.01596.x.
  15. Beckett N., Peters R., Tuomilehto J. et al. Immediate and late benefits of treating very elderly people with hypertension: Results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial. BMJ. 2012; 344: d7541. https://dx.doi.org/10.1136/bmj.d7541.
  16. Marre M., Puig J., Kokot F. et al. Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: The NESTOR Study. J Hypertens. 2004; 22(8): 1613–22. https://dx.doi.org/10.1097/01.hjh.0000133733.32125.09.
  17. Zhang Y., Agnoletti D., Wang J. et al. Natriuresis and blood pressure reduction in hypertensive patients with diabetes mellitus: The NESTOR study. J Am Soc Hypertens. 2015; 9(1): 21–28. https://dx.doi.org/10.1016/j.jash.2014.10.003.
  18. Hanon O., Boully C., Caillard L. et al. Treatment of hypertensive patients with diabetes and microalbuminuria with combination indapamide SR/amlodipine: Retrospective analysis of NESTOR. Am J Hypertens. 2015; 28(8) :1064–71. https://dx.doi.org/10.1093/ajh/hpu297.
  19. Holzgreve Н., Risler T., Trenkwalder P. Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: The PRIMUS study. Curr Med Res Opin. 2006; 22(9): 1849–58. https://dx.doi.org/10.1185/030079906X132433.
  20. Mourad J.J., Nguyen V., Lopez-Sublet M., Waeber B. Вlood pressure normalization in a large population of hypertensive patients treated with perindopril/indapamide combination: Results of the OPTIMAX trial. Vasc Health Risk Manag. 2007; 3(1): 173–80.
  21. Akram J., Sheikh U., Mahmood M., Donnelly R. Antihypertensive efficacy of indapamide SR in hypertensive patients uncontrolled with a background therapy: The NATIVE study. Curr Med Res Opin. 2007; 23(12): 2929–36. https://dx.doi.org/10.1185/030079907X242674.
  22. Suchard M., Schuemie M., Krumholz H. et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: A systematic, multinational, large-scale analysis. Lancet. 2019; 394(10211): 1816–26. https://dx.doi.org/10.1016/S0140-6736(19)32317-7.
  23. Chen Y.J., Li L.J., Tang W.L. et al. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension. Cochrane Database Syst Rev. 2018; 11(11): CD008170. https://dx.doi.org/10.1002/14651858.CD008170.pub3.
  24. Bahtiyar G., Gutterman D., Lebovitz H. Heart failure: A major cardiovascular complication of diabetes mellitus. Curr Diab Rep. 2016; 16(11): 116. https://dx.doi.org/10.1007/s11892-016-0809-4.
  25. de Boer I., Bangalore S., Benetos A. et al. Diabetes and hypertension: A position statement by the American Diabetes Association. Diabetes Care. 2017; 40(9): 1273–284. https://dx.doi.org/10.2337/dci17-0026.
  26. Wang S., Li J., Zhou X. et al. Comparison between the effects of hydrochlorothiazide and indapamide on the kidney in hypertensive patients inadequately controlled with losartan. J Hum Hypertens. 2017; 31(12): 848–54. https://dx.doi.org/10.1038/jhh.2017.51.
  27. Vinereanu D., Dulgheru R., Magda S. et al. The effect of indapamide versus hydrochlorothiazide on ventricular and arterial function in patients with hypertension and diabetes: Results of a randomized trial. Am Heart J. 2014; 168(4): 446–56. https://dx.doi.org/10.1016/j.ahj.2014.06.010.
  28. Senior R., Imbs J.L., Bory M. et al. Indapamide reduces hypertensive left ventricular hypertrophy: An international multicenter study. J Cardiovasc Pharmacol. 1993; 22 (Suppl 6): S106–10.
  29. Liang W., Ma H., Cao L. et al. Comparison of thiazide-like diuretics versus thiazide-type diuretics: A meta-analysis. J Cell Mol Med. 2017; 21(11): 2634–42. https://dx.doi.org/10.1111/jcmm.13205.
  30. Olde Engberink R.H., Frenkel W.J., van den Bogaard B. et al. Effects of thiazide-type and thiazide-like diuretics on cardiovascular events and mortality: Systematic review and meta-analysis. Hypertension. 2015; 65(5): 1033–40. https://dx.doi.org/10.1161/HYPERTENSIONAHA.114.05122.
  31. Thomopoulos C., Parati G., Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs – overview and meta-analyses. J Hypertens. 2015; 33(2): 195–211. https://dx.doi.org/10.1097/HJH.0000000000000447.
  32. Pedersen S., Gaist D., Schmidt S. et al. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark. J Am Acad Dermatol. 2018; 78(4): 673–81e2. https://dx.doi.org/10.1016/j.jaad.2017.11.042.
  33. Pottegard A., Pedersen S., Schmidt S. et al. Association of hydrochlorothiazide use and risk of malignant melanoma. JAMA Intern Med. 2018; 178(8): 1120–22. https://dx.doi.org/10.1001/jamainternmed.2018.1652.
  34. Lu M., Ma L., Wang X. et al. Indapamide suppresses amyloid-β production in cellular models of Alzheimer’s disease through regulating BACE1 activity. Int J Clin Exp Med. 2017; 10(4): 5922–30.
  35. Kaplan N. Indapamide. Is it the better diuretic for hypertension? Hypertension. 2015; 65(5): 983–84. https://dx.doi.org/10.1161/HYPERTENSIONAHA.115.05138.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ООО «Бионика Медиа», 2023

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах